Back
AbbVie Stock Predictions
Buy
64
ABBV
AbbVie
Last Price:
166.43
Seasonality Move:
-0.2%
7 Day Trial
ALL ACCESS PASS
$
7
AbbVie Stock Forecast
- Over the next 52 weeks, AbbVie has on average historically risen by 14.3% based on the past 11 years of stock performance.
- AbbVie has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
-
Is AbbVie Stock Undervalued?
The current AbbVie [ABBV] share price is $166.42. The Score for ABBV is 64, which is 28% above its historic median score of 50, and infers lower risk than normal. - ABBV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will AbbVie Stock Go Up Next Year?
- Over the next 52 weeks, AbbVie has on average historically risen by 14.3% based on the past 11 years of stock performance.
AbbVie Stock Rating
Buy
64
AbbVie (ABBV)
is a Buy
Is AbbVie overpriced?
- AbbVie has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
AbbVie Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
abbvieinvestor.com
52-Week Data
52-Week High:
182.89
52-Week Low:
130.96
Prediction Charts
Market Cap:
293.88B
Price in USD:
166.42
Volume:
4.95M
Beta:
0.81
Technical Analysis
SMA50:
169.82
SMA100:
169.34
SMA200:
158.30
52-Wk Change:
16.09%
Stock Predictions
-
Is AbbVie stock public?
Yes, AbbVie is a publicly traded company. -
What is the AbbVie stock quote today?
The AbbVie stock price is 166.42 USD today. -
How to buy AbbVie stock online?
You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 161.27 | 162.64 | 163.05 | 159.69 |
May-1 | 162.09 | 161.72 | 163.69 | 161.14 |
May-2 | 162.17 | 160.81 | 162.44 | 158.12 |
May-3 | 161.16 | 163.79 | 164.25 | 160.74 |
May-6 | 164.41 | 162.73 | 164.63 | 161.00 |
May-7 | 163.36 | 162.55 | 163.99 | 161.89 |
May-8 | 162.14 | 160.45 | 162.90 | 159.87 |
May-9 | 160.81 | 160.40 | 161.32 | 160.02 |
May-10 | 160.71 | 160.75 | 161.44 | 160.35 |
May-13 | 161.28 | 161.28 | 162.57 | 160.80 |
May-14 | 161.65 | 161.59 | 162.25 | 159.72 |
May-15 | 162.31 | 163.79 | 164.42 | 161.87 |
May-16 | 163.45 | 164.35 | 164.93 | 162.18 |
May-17 | 165.39 | 166.42 | 166.49 | 164.49 |
AbbVie Earnings
AbbVie Earnings Report: Per Share AbbVie Earnings Q1 Q2 Q3 and Q4 last year and next year.
AbbVie Forecast Revenue Growth
AbbVie Stock Analysis: Historical quarterly revenues per share for AbbVie and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.20 per share, an increase this year of $0.10 per share, and an increase next year of $0.83 per share.
* AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.